Kurs
+4,21%
Kalender
| Est. tid* | ||
| 2026-02-20 | 12:10 | Bokslutskommuniké 2025 |
| 2025-11-11 | 12:10 | Kvartalsrapport 2025-Q3 |
| 2025-08-29 | 12:10 | Kvartalsrapport 2025-Q2 |
| 2025-05-26 | - | X-dag ordinarie utdelning SDET 0.00 SEK |
| 2025-05-23 | - | Årsstämma |
| 2025-04-30 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-21 | - | Bokslutskommuniké 2024 |
| 2024-11-08 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-30 | - | Kvartalsrapport 2024-Q2 |
| 2024-08-21 | - | Extra Bolagsstämma 2024 |
| 2024-05-27 | - | X-dag ordinarie utdelning SDET 0.00 SEK |
| 2024-05-24 | - | Årsstämma |
| 2024-05-24 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-22 | - | Bokslutskommuniké 2023 |
| 2023-11-30 | - | Extra Bolagsstämma 2023 |
| 2023-11-06 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-28 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-26 | - | X-dag ordinarie utdelning SDET 0.00 SEK |
| 2023-05-25 | - | Årsstämma |
| 2023-05-25 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-24 | - | Bokslutskommuniké 2022 |
| 2022-11-11 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-25 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-08 | - | Årsstämma |
| 2022-05-24 | - | Kvartalsrapport 2022-Q1 |
| 2022-05-19 | - | X-dag ordinarie utdelning SDET 0.00 SEK |
| 2022-02-25 | - | Bokslutskommuniké 2021 |
| 2021-11-23 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-31 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-20 | - | Kvartalsrapport 2021-Q1 |
| 2021-05-04 | - | X-dag ordinarie utdelning SDET 0.00 SEK |
| 2021-05-03 | - | Årsstämma |
| 2021-02-26 | - | Bokslutskommuniké 2020 |
| 2020-11-27 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-28 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-30 | - | X-dag ordinarie utdelning SDET 0.00 SEK |
| 2020-06-29 | - | Årsstämma |
| 2020-05-04 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-17 | - | Bokslutskommuniké 2019 |
| 2019-11-11 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-19 | - | Kvartalsrapport 2019-Q2 |
| 2019-08-15 | - | Extra Bolagsstämma 2019 |
| 2019-05-13 | - | Kvartalsrapport 2019-Q1 |
| 2019-05-03 | - | X-dag ordinarie utdelning SDET 0.00 SEK |
| 2019-05-02 | - | Årsstämma |
| 2019-02-12 | - | Bokslutskommuniké 2018 |
| 2018-11-12 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-20 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-11 | - | Kvartalsrapport 2018-Q1 |
| 2018-05-03 | - | X-dag ordinarie utdelning SDET 0.00 SEK |
| 2018-05-02 | - | Årsstämma |
| 2018-02-19 | - | Bokslutskommuniké 2017 |
| 2017-11-13 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-21 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-16 | - | X-dag ordinarie utdelning SDET 0.00 SEK |
| 2017-05-15 | - | Årsstämma |
| 2017-05-12 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-20 | - | Bokslutskommuniké 2016 |
| 2016-11-14 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-22 | - | Kvartalsrapport 2016-Q2 |
| 2016-06-20 | - | X-dag ordinarie utdelning SDET 0.00 SEK |
| 2016-06-17 | - | Årsstämma |
| 2016-05-19 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-22 | - | Bokslutskommuniké 2015 |
| 2015-11-16 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-24 | - | Kvartalsrapport 2015-Q2 |
| 2015-06-04 | - | X-dag ordinarie utdelning SDET 0.00 SEK |
| 2015-06-03 | - | Årsstämma |
| 2015-05-12 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-26 | - | Bokslutskommuniké 2014 |
| 2014-11-07 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-28 | - | Kvartalsrapport 2014-Q2 |
| 2014-06-04 | - | X-dag ordinarie utdelning SDET 0.00 SEK |
| 2014-06-03 | - | Årsstämma |
| 2014-05-28 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-26 | - | Bokslutskommuniké 2013 |
| 2013-11-21 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-29 | - | Kvartalsrapport 2013-Q2 |
| 2013-06-18 | - | X-dag ordinarie utdelning SDET 0.00 SEK |
| 2013-06-17 | - | Årsstämma |
| 2013-05-17 | - | Kvartalsrapport 2013-Q1 |
| 2013-04-03 | - | 15-7 2013 |
| 2013-03-13 | - | Extra Bolagsstämma 2013 |
| 2013-01-28 | - | Bokslutskommuniké 2012 |
| 2012-11-22 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-29 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-23 | - | Kvartalsrapport 2012-Q1 |
| 2012-03-08 | - | X-dag ordinarie utdelning SDET 0.00 SEK |
| 2012-03-07 | - | Årsstämma |
| 2012-02-06 | - | Bokslutskommuniké 2011 |
| 2011-11-24 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-25 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-13 | - | X-dag ordinarie utdelning SDET 0.00 SEK |
| 2011-05-12 | - | Årsstämma |
| 2011-05-05 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-07 | - | Bokslutskommuniké 2010 |
| 2010-05-07 | - | X-dag ordinarie utdelning SDET 0.00 SEK |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
SensoDetect AB, a pioneer in neuropsychiatric screening and diagnostic support, today announced promising interim results from its clinical ASD study in Saudi Arabia.
Interim Findings: Validation of Method and AI Performance
"The initial data confirms the feasibility of our method and shows the measurement process works as intended," said PA Hedin, CEO of SensoDetect AB. "Critically, and not a part of the interim analysis, our AI model is already demonstrating strong performance in detecting ASD-specific biomarkers-which will further improve the final results as we incorporate additional local data from Saudi Arabia."
About the Clinical Study
The study evaluates SensoDetect® Diagnostics (SDD), an advanced neurophysiological tool designed to support earlier and more precise ASD screening. By analyzing auditory brainstem responses (ABR), SDD provides objective data to complement traditional behavioral assessments.
Key Study Aspects:
- Conducted in collaboration with leading Saudi medical institutions
- Aims to validate SDD's effectiveness across diverse populations
- Includes early screening potential already 24 hours after birth
Why This Matters
- Early Diagnosis Gap: Many children with ASD in Saudi Arabia and worldwide face delayed diagnosis due to reliance on subjective behavioral evaluations. Best outcomes for ASD occur with diagnosis before age 3. The SDD offers a faster, more objective approach
- Early intervention demand: best outcomes for ASD occur with diagnosis before age 3
- Saudi Arabia's Strategic Role: With 12%+ CAGR growth in ASD diagnostics and Vision 2030 healthcare investments, the country is an ideal validation ground
- Global Potential: Successful results could redefine ASD screening worldwide
Leadership Perspectives
"This study marks a pivotal step in revolutionizing ASD diagnostics," added CEO PA Hedin. "Our goal is to enable earlier intervention and better outcomes globally."
Dr. Saleh, principal investigator of the study in Saudi Arabia, noted:
"SDD could set a new global standard for ASD diagnosis. We're proud to contribute to this transformative research."
Market Opportunity in Saudi Arabia
- 50+ target clinics/hospitals in major cities (Riyadh, Jeddah)
- Government and private sector demand for AI-driven diagnostics
- Telemedicine integration potential under Vision 2030
For further information, please contact:
PA Hedin, CEO Sensodetect AB
+46 (0)73-068 64 20
pa.hedin@sensodetect.com